Validating the Use of Frailty Measurements to Predict Care & Quality of Life

NCT06325241 | Active Not Recruiting

• 1 other identifier: 20200048-01H
• Study Type: observational
• Target: 123
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this research program is to validate frailty measurements as a risk stratification tool to predict deteriorations in patient-reported outcomes, to gain a better understanding of patient preferences for care within varying degrees of frailty, and to assess differences in frailty measurement between patients and their clinicians. This work will provide a foundation in the development of customized interventions for people with COPD and varying degrees of frailty, with the goal of improving quality of life and optimizing health system service delivery for patients and their care givers.

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Frailty; Care expectations

Outcome Measures

Primary Outcomes (1)

• Respiratory Health Related Quality of Life

  measured by the validated short version of St. Georges Respiratory Questionnaire (not a scale).

  12 months

Secondary Outcomes (4)

• Burden of symptoms - COPD Assessment

  12 months

• Burden of symptoms - Dyspnea

  12 months

• Psycho-social well being - Anxiety

  12 months

• Psycho-social well being - Depression

  12 months

Interventions

No intervention OTHER

There is no intervention. This is an observational study.

Also known as: there are no other names.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

French or English speaking outpatients of the Ottawa Hospital Respirology clinic who are diagnoses with Chronic Obstructive Pulmonary Disease, which is confirmed by pulmonary function testing who are able to speak on the phone for at least 10 minutes.

You may qualify if:

• Outpatients of The Ottawa Hospital Respirology clinic
• Chronic Obstructive Pulmonary Disease diagnosis confirmed by pulmonary function testing.
• English or French speaking

You may not qualify if:

• patients with a known diagnosis of severe cognitive impairment

Sponsors & Collaborators

• Ottawa Hospital Research Institute: lead

Study Sites (1)

The Ottawa Hospital, General Campus

Ottawa, Ontario, K1J 0J2, Canada

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Frailty

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Staff Physician, Investigator

Study Record Dates

• First Submitted: November 10, 2023
• First Posted: March 22, 2024
• Study Start: December 12, 2022
• Primary Completion: March 31, 2025
• Study Completion: March 31, 2025
• Last Updated: April 24, 2024

Record last verified: 2024-04

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)